Pyxis Oncology, Inc. (PYXS) Form 424B5 — Sep 29, 2026

$PYXSForm 424B5Filed Sep 29, 2026, 4:19 PM ET0001437749-26-031470Original filing

Pyxis Oncology filed Supplement No. 1 to its November 26, 2025 ATM prospectus supplement, terminating the continuous offering program effective September 29, 2026.

Key figures

Atm capacity original: $150,000,000
Shares sold under atm: 0
Atm capacity after termination: $0

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.